

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 5.86064195 |
| 2 | sodium ion export (GO:0071436) | 5.41865221 |
| 3 | protein localization to synapse (GO:0035418) | 4.98281775 |
| 4 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.97127789 |
| 5 | vocalization behavior (GO:0071625) | 4.91984238 |
| 6 | L-amino acid import (GO:0043092) | 4.88574689 |
| 7 | regulation of glutamate secretion (GO:0014048) | 4.78337541 |
| 8 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.77656872 |
| 9 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 4.75950705 |
| 10 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.73421836 |
| 11 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.72485765 |
| 12 | glutamate receptor signaling pathway (GO:0007215) | 4.69107819 |
| 13 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.64026628 |
| 14 | behavioral defense response (GO:0002209) | 4.61766755 |
| 15 | behavioral fear response (GO:0001662) | 4.61766755 |
| 16 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.47337672 |
| 17 | positive regulation of neurotransmitter secretion (GO:0001956) | 4.46503557 |
| 18 | synaptic vesicle endocytosis (GO:0048488) | 4.42041570 |
| 19 | exploration behavior (GO:0035640) | 4.40021904 |
| 20 | regulation of female receptivity (GO:0045924) | 4.39076675 |
| 21 | synaptic vesicle exocytosis (GO:0016079) | 4.38324297 |
| 22 | neurotransmitter transport (GO:0006836) | 4.36104809 |
| 23 | fear response (GO:0042596) | 4.31821328 |
| 24 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.31783185 |
| 25 | locomotory exploration behavior (GO:0035641) | 4.30961154 |
| 26 | long-term synaptic potentiation (GO:0060291) | 4.29741668 |
| 27 | synaptic transmission, dopaminergic (GO:0001963) | 4.26074018 |
| 28 | behavioral response to cocaine (GO:0048148) | 4.23309518 |
| 29 | cerebellar granule cell differentiation (GO:0021707) | 4.22254097 |
| 30 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.22236474 |
| 31 | neuron-neuron synaptic transmission (GO:0007270) | 4.15659159 |
| 32 | neuron recognition (GO:0008038) | 4.13607171 |
| 33 | synaptic transmission, glutamatergic (GO:0035249) | 4.11974729 |
| 34 | regulation of voltage-gated calcium channel activity (GO:1901385) | 4.08846902 |
| 35 | amino acid import (GO:0043090) | 4.07930652 |
| 36 | potassium ion homeostasis (GO:0055075) | 4.07699303 |
| 37 | regulation of dendritic spine morphogenesis (GO:0061001) | 4.07471020 |
| 38 | female mating behavior (GO:0060180) | 4.06673905 |
| 39 | neuron cell-cell adhesion (GO:0007158) | 4.03018867 |
| 40 | neurotransmitter uptake (GO:0001504) | 4.01918229 |
| 41 | cell communication by electrical coupling (GO:0010644) | 4.00356789 |
| 42 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.99414771 |
| 43 | regulation of neurotransmitter secretion (GO:0046928) | 3.98761485 |
| 44 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.94398642 |
| 45 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 3.92131523 |
| 46 | regulation of neurotransmitter levels (GO:0001505) | 3.89567545 |
| 47 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.84694736 |
| 48 | regulation of synaptic plasticity (GO:0048167) | 3.84577609 |
| 49 | dendritic spine organization (GO:0097061) | 3.79049867 |
| 50 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.77432012 |
| 51 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 3.73029173 |
| 52 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 3.73029173 |
| 53 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.72713974 |
| 54 | regulation of postsynaptic membrane potential (GO:0060078) | 3.71189106 |
| 55 | positive regulation of synapse maturation (GO:0090129) | 3.69548456 |
| 56 | postsynaptic membrane organization (GO:0001941) | 3.69489660 |
| 57 | glutamate secretion (GO:0014047) | 3.66890127 |
| 58 | long-term memory (GO:0007616) | 3.65995375 |
| 59 | positive regulation of neurotransmitter transport (GO:0051590) | 3.63505367 |
| 60 | dendritic spine morphogenesis (GO:0060997) | 3.61405618 |
| 61 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.61285792 |
| 62 | regulation of cell communication by electrical coupling (GO:0010649) | 3.61263738 |
| 63 | layer formation in cerebral cortex (GO:0021819) | 3.60969640 |
| 64 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.58996864 |
| 65 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.58786946 |
| 66 | cell communication involved in cardiac conduction (GO:0086065) | 3.58362801 |
| 67 | potassium ion import (GO:0010107) | 3.56664539 |
| 68 | positive regulation of cellular response to oxidative stress (GO:1900409) | 3.56077338 |
| 69 | positive regulation of response to oxidative stress (GO:1902884) | 3.56077338 |
| 70 | regulation of neurotransmitter uptake (GO:0051580) | 3.55679743 |
| 71 | response to histamine (GO:0034776) | 3.54270138 |
| 72 | regulation of neurotransmitter transport (GO:0051588) | 3.53208830 |
| 73 | cellular sodium ion homeostasis (GO:0006883) | 3.52958165 |
| 74 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 3.48516044 |
| 75 | axonal fasciculation (GO:0007413) | 3.48387252 |
| 76 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.48378943 |
| 77 | positive regulation of dendritic spine development (GO:0060999) | 3.47444821 |
| 78 | regulation of dopamine metabolic process (GO:0042053) | 3.46799149 |
| 79 | regulation of catecholamine metabolic process (GO:0042069) | 3.46799149 |
| 80 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.46296190 |
| 81 | cellular potassium ion homeostasis (GO:0030007) | 3.44180117 |
| 82 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.44124478 |
| 83 | regulation of dendritic spine development (GO:0060998) | 3.43286660 |
| 84 | regulation of Rac GTPase activity (GO:0032314) | 3.43095229 |
| 85 | vesicle docking involved in exocytosis (GO:0006904) | 3.42034228 |
| 86 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.41585226 |
| 87 | membrane depolarization during action potential (GO:0086010) | 3.38873086 |
| 88 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.38254253 |
| 89 | regulation of vesicle fusion (GO:0031338) | 3.38177764 |
| 90 | innervation (GO:0060384) | 3.36715554 |
| 91 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.36531460 |
| 92 | regulation of synapse structural plasticity (GO:0051823) | 3.35387737 |
| 93 | negative regulation of amine transport (GO:0051953) | 3.34496989 |
| 94 | negative regulation of neurotransmitter transport (GO:0051589) | 3.33210514 |
| 95 | cochlea development (GO:0090102) | 3.31324867 |
| 96 | neuromuscular process controlling posture (GO:0050884) | 3.31290416 |
| 97 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.31062265 |
| 98 | transmission of nerve impulse (GO:0019226) | 3.30993317 |
| 99 | regulation of synaptic vesicle transport (GO:1902803) | 3.28938721 |
| 100 | learning (GO:0007612) | 3.27786993 |
| 101 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.27465994 |
| 102 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.26543398 |
| 103 | membrane depolarization (GO:0051899) | 3.26378770 |
| 104 | vesicle docking (GO:0048278) | 3.24268050 |
| 105 | acidic amino acid transport (GO:0015800) | 3.23797180 |
| 106 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 3.22438207 |
| 107 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.21491786 |
| 108 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.20865939 |
| 109 | neuronal ion channel clustering (GO:0045161) | 3.20768672 |
| 110 | negative regulation of amino acid transport (GO:0051956) | 3.20173601 |
| 111 | neuromuscular process controlling balance (GO:0050885) | 3.20125432 |
| 112 | neuronal action potential propagation (GO:0019227) | 3.19088913 |
| 113 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 3.18176555 |
| 114 | regulation of synapse maturation (GO:0090128) | 3.16548890 |
| 115 | proline transport (GO:0015824) | 3.15864543 |
| 116 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.15561528 |
| 117 | synaptic transmission (GO:0007268) | 3.15420687 |
| 118 | regulation of synaptic transmission (GO:0050804) | 3.13840616 |
| 119 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.13097530 |
| 120 | presynaptic membrane assembly (GO:0097105) | 3.12995035 |
| 121 | long term synaptic depression (GO:0060292) | 3.11959784 |
| 122 | positive regulation of membrane potential (GO:0045838) | 3.11347888 |
| 123 | glycosphingolipid biosynthetic process (GO:0006688) | 3.10857966 |
| 124 | establishment of synaptic vesicle localization (GO:0097480) | 3.10360511 |
| 125 | synaptic vesicle transport (GO:0048489) | 3.10360511 |
| 126 | inner ear receptor cell development (GO:0060119) | 3.09689113 |
| 127 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 3.09135866 |
| 128 | activation of protein kinase A activity (GO:0034199) | 3.09065226 |
| 129 | gamma-aminobutyric acid transport (GO:0015812) | 3.08322181 |
| 130 | response to amphetamine (GO:0001975) | 3.08067240 |
| 131 | synaptic vesicle maturation (GO:0016188) | 3.07750834 |
| 132 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.06562517 |
| 133 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.06451641 |
| 134 | dopamine transport (GO:0015872) | 3.05554643 |
| 135 | vesicle transport along microtubule (GO:0047496) | 3.05224702 |
| 136 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 3.04137382 |
| 137 | extracellular fibril organization (GO:0043206) | 3.03845641 |
| 138 | regulation of sodium ion transmembrane transport (GO:1902305) | 3.03409281 |
| 139 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.03313398 |
| 140 | neurotransmitter secretion (GO:0007269) | 3.01086263 |
| 141 | ephrin receptor signaling pathway (GO:0048013) | 3.00495501 |
| 142 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.99476632 |
| 143 | dicarboxylic acid transport (GO:0006835) | 2.95914184 |
| 144 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.95334891 |
| 145 | L-glutamate transport (GO:0015813) | 2.94618992 |
| 146 | detection of calcium ion (GO:0005513) | 2.94431959 |
| 147 | positive regulation of synaptic transmission (GO:0050806) | 2.93685290 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.95049475 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.80716979 |
| 3 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.49865779 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.47377871 |
| 5 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.44568456 |
| 6 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 3.10927788 |
| 7 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 3.02534545 |
| 8 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.96461961 |
| 9 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.96461961 |
| 10 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.94005738 |
| 11 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.79460302 |
| 12 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.75953253 |
| 13 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.74958806 |
| 14 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.66225356 |
| 15 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.63089642 |
| 16 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.62623273 |
| 17 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.58268550 |
| 18 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.51489825 |
| 19 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.30048285 |
| 20 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.29627899 |
| 21 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.27774959 |
| 22 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.20918016 |
| 23 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.10549881 |
| 24 | * THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.99167588 |
| 25 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.87618262 |
| 26 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.87198287 |
| 27 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.85419921 |
| 28 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.80524370 |
| 29 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.76237604 |
| 30 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.75213076 |
| 31 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.74594463 |
| 32 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.74196521 |
| 33 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.73386162 |
| 34 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.72253929 |
| 35 | FUS_26573619_Chip-Seq_HEK293_Human | 1.71856839 |
| 36 | VDR_22108803_ChIP-Seq_LS180_Human | 1.69262139 |
| 37 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.68647492 |
| 38 | P300_19829295_ChIP-Seq_ESCs_Human | 1.66368616 |
| 39 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.65568663 |
| 40 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.65447620 |
| 41 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.64952964 |
| 42 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.58005803 |
| 43 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.57591025 |
| 44 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.57026509 |
| 45 | TP53_16413492_ChIP-PET_HCT116_Human | 1.48499756 |
| 46 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.48202562 |
| 47 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.46362319 |
| 48 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.45432877 |
| 49 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.45337978 |
| 50 | AR_25329375_ChIP-Seq_VCAP_Human | 1.42663125 |
| 51 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.42524492 |
| 52 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.41521954 |
| 53 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.41434715 |
| 54 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.40814929 |
| 55 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.39196801 |
| 56 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.36572176 |
| 57 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.36314673 |
| 58 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.32083764 |
| 59 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.28246937 |
| 60 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.26986022 |
| 61 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.23580049 |
| 62 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.23237262 |
| 63 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.23224558 |
| 64 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.22765258 |
| 65 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.22728849 |
| 66 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.22208091 |
| 67 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.21348294 |
| 68 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.20288129 |
| 69 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.20138666 |
| 70 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.17544460 |
| 71 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.15564599 |
| 72 | JUN_21703547_ChIP-Seq_K562_Human | 1.15351963 |
| 73 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.13371626 |
| 74 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.12754068 |
| 75 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.12600889 |
| 76 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.11629952 |
| 77 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.11609748 |
| 78 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.09583141 |
| 79 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.07300239 |
| 80 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.06712379 |
| 81 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.05419785 |
| 82 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.04765824 |
| 83 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.04419666 |
| 84 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.03494341 |
| 85 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.02660486 |
| 86 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.01153722 |
| 87 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.00756085 |
| 88 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.00226195 |
| 89 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.99346768 |
| 90 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.99179098 |
| 91 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97727590 |
| 92 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97135839 |
| 93 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.97135839 |
| 94 | AR_19668381_ChIP-Seq_PC3_Human | 0.96997412 |
| 95 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.96648187 |
| 96 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.96629308 |
| 97 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.96629233 |
| 98 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.96516388 |
| 99 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.95904924 |
| 100 | * STAT3_23295773_ChIP-Seq_U87_Human | 0.94878098 |
| 101 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.94827914 |
| 102 | TCF4_23295773_ChIP-Seq_U87_Human | 0.94566798 |
| 103 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.94422407 |
| 104 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.92462702 |
| 105 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.91394415 |
| 106 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90880557 |
| 107 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.89908760 |
| 108 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.89578998 |
| 109 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.89439695 |
| 110 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.89439695 |
| 111 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.89296206 |
| 112 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.88643652 |
| 113 | KDM2B_26808549_Chip-Seq_K562_Human | 0.87262484 |
| 114 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.87196209 |
| 115 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.86142629 |
| 116 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.86072521 |
| 117 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.86045273 |
| 118 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.86004361 |
| 119 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.82690635 |
| 120 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.82646049 |
| 121 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.82607228 |
| 122 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.82295520 |
| 123 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.79534525 |
| 124 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.78442301 |
| 125 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.77925906 |
| 126 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.76948708 |
| 127 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.76472751 |
| 128 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.76436769 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.54110945 |
| 2 | MP0003880_abnormal_central_pattern | 6.20069411 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 4.05260552 |
| 4 | MP0002063_abnormal_learning/memory/cond | 3.60657113 |
| 5 | MP0009745_abnormal_behavioral_response | 3.52571782 |
| 6 | MP0004270_analgesia | 3.35313350 |
| 7 | MP0003329_amyloid_beta_deposits | 2.84526408 |
| 8 | MP0002064_seizures | 2.83708014 |
| 9 | MP0002572_abnormal_emotion/affect_behav | 2.80967108 |
| 10 | MP0001968_abnormal_touch/_nociception | 2.77998534 |
| 11 | MP0002736_abnormal_nociception_after | 2.70443373 |
| 12 | MP0001440_abnormal_grooming_behavior | 2.53135019 |
| 13 | MP0001501_abnormal_sleep_pattern | 2.48889177 |
| 14 | MP0002822_catalepsy | 2.48106248 |
| 15 | MP0002837_dystrophic_cardiac_calcinosis | 2.37324842 |
| 16 | MP0002272_abnormal_nervous_system | 2.32073803 |
| 17 | MP0001486_abnormal_startle_reflex | 2.17137706 |
| 18 | MP0002735_abnormal_chemical_nociception | 2.08584494 |
| 19 | MP0000778_abnormal_nervous_system | 1.99216173 |
| 20 | MP0002184_abnormal_innervation | 1.92281586 |
| 21 | MP0002734_abnormal_mechanical_nocicepti | 1.83700974 |
| 22 | MP0001984_abnormal_olfaction | 1.80061866 |
| 23 | MP0006276_abnormal_autonomic_nervous | 1.77155241 |
| 24 | MP0009780_abnormal_chondrocyte_physiolo | 1.76820987 |
| 25 | MP0004858_abnormal_nervous_system | 1.75382228 |
| 26 | MP0009046_muscle_twitch | 1.72129594 |
| 27 | MP0002067_abnormal_sensory_capabilities | 1.70778295 |
| 28 | MP0001529_abnormal_vocalization | 1.68966441 |
| 29 | MP0002557_abnormal_social/conspecific_i | 1.61392663 |
| 30 | MP0001905_abnormal_dopamine_level | 1.60264469 |
| 31 | MP0008877_abnormal_DNA_methylation | 1.60237572 |
| 32 | MP0001188_hyperpigmentation | 1.51206349 |
| 33 | MP0002733_abnormal_thermal_nociception | 1.50931134 |
| 34 | MP0001970_abnormal_pain_threshold | 1.49513270 |
| 35 | MP0000604_amyloidosis | 1.45362626 |
| 36 | MP0002909_abnormal_adrenal_gland | 1.43511770 |
| 37 | MP0005394_taste/olfaction_phenotype | 1.42944404 |
| 38 | MP0005499_abnormal_olfactory_system | 1.42944404 |
| 39 | MP0004811_abnormal_neuron_physiology | 1.42117487 |
| 40 | MP0004885_abnormal_endolymph | 1.41178619 |
| 41 | MP0000955_abnormal_spinal_cord | 1.40500370 |
| 42 | MP0005386_behavior/neurological_phenoty | 1.38858323 |
| 43 | MP0004924_abnormal_behavior | 1.38858323 |
| 44 | MP0006292_abnormal_olfactory_placode | 1.37968949 |
| 45 | MP0005409_darkened_coat_color | 1.36092058 |
| 46 | MP0002882_abnormal_neuron_morphology | 1.35241637 |
| 47 | MP0004147_increased_porphyrin_level | 1.32788329 |
| 48 | MP0003879_abnormal_hair_cell | 1.31188657 |
| 49 | MP0005423_abnormal_somatic_nervous | 1.28708209 |
| 50 | MP0005187_abnormal_penis_morphology | 1.26562228 |
| 51 | MP0005646_abnormal_pituitary_gland | 1.26144100 |
| 52 | MP0010234_abnormal_vibrissa_follicle | 1.25666596 |
| 53 | MP0001177_atelectasis | 1.25589496 |
| 54 | MP0002066_abnormal_motor_capabilities/c | 1.25506530 |
| 55 | MP0003123_paternal_imprinting | 1.22039235 |
| 56 | MP0005645_abnormal_hypothalamus_physiol | 1.12738146 |
| 57 | MP0000678_abnormal_parathyroid_gland | 1.12083156 |
| 58 | MP0010386_abnormal_urinary_bladder | 1.08849440 |
| 59 | MP0000920_abnormal_myelination | 1.08815613 |
| 60 | MP0003938_abnormal_ear_development | 1.07972532 |
| 61 | MP0008569_lethality_at_weaning | 1.07309141 |
| 62 | MP0006036_abnormal_mitochondrial_physio | 1.06757185 |
| 63 | MP0004484_altered_response_of | 1.04765801 |
| 64 | MP0002152_abnormal_brain_morphology | 1.04296037 |
| 65 | MP0001963_abnormal_hearing_physiology | 1.01047666 |
| 66 | MP0003631_nervous_system_phenotype | 1.00654089 |
| 67 | MP0005551_abnormal_eye_electrophysiolog | 0.98744776 |
| 68 | MP0000751_myopathy | 0.98390171 |
| 69 | MP0001502_abnormal_circadian_rhythm | 0.97876005 |
| 70 | MP0002876_abnormal_thyroid_physiology | 0.97574539 |
| 71 | MP0001485_abnormal_pinna_reflex | 0.96921598 |
| 72 | MP0003632_abnormal_nervous_system | 0.96146990 |
| 73 | MP0005535_abnormal_body_temperature | 0.95150840 |
| 74 | MP0003633_abnormal_nervous_system | 0.94737816 |
| 75 | MP0008872_abnormal_physiological_respon | 0.93206064 |
| 76 | MP0009379_abnormal_foot_pigmentation | 0.91788866 |
| 77 | MP0002638_abnormal_pupillary_reflex | 0.91205508 |
| 78 | MP0003075_altered_response_to | 0.90853191 |
| 79 | MP0002234_abnormal_pharynx_morphology | 0.90641261 |
| 80 | MP0001664_abnormal_digestion | 0.90188912 |
| 81 | MP0003787_abnormal_imprinting | 0.89575038 |
| 82 | MP0004085_abnormal_heartbeat | 0.86543352 |
| 83 | MP0003137_abnormal_impulse_conducting | 0.86235947 |
| 84 | MP0000026_abnormal_inner_ear | 0.85369333 |
| 85 | MP0002069_abnormal_eating/drinking_beha | 0.84816482 |
| 86 | MP0002752_abnormal_somatic_nervous | 0.84733473 |
| 87 | MP0008789_abnormal_olfactory_epithelium | 0.81981270 |
| 88 | MP0000013_abnormal_adipose_tissue | 0.81341929 |
| 89 | MP0002229_neurodegeneration | 0.78102646 |
| 90 | MP0008874_decreased_physiological_sensi | 0.77072546 |
| 91 | MP0004145_abnormal_muscle_electrophysio | 0.75883622 |
| 92 | MP0004510_myositis | 0.75498299 |
| 93 | MP0004742_abnormal_vestibular_system | 0.75145310 |
| 94 | MP0004233_abnormal_muscle_weight | 0.74965402 |
| 95 | MP0003122_maternal_imprinting | 0.74440995 |
| 96 | MP0000647_abnormal_sebaceous_gland | 0.74298040 |
| 97 | MP0003638_abnormal_response/metabolism_ | 0.72907560 |
| 98 | MP0003634_abnormal_glial_cell | 0.71789847 |
| 99 | MP0002090_abnormal_vision | 0.71745021 |
| 100 | MP0008875_abnormal_xenobiotic_pharmacok | 0.70711491 |
| 101 | MP0000631_abnormal_neuroendocrine_gland | 0.70481662 |
| 102 | MP0001986_abnormal_taste_sensitivity | 0.70309568 |
| 103 | MP0004215_abnormal_myocardial_fiber | 0.64813846 |
| 104 | MP0001346_abnormal_lacrimal_gland | 0.63966674 |
| 105 | MP0002102_abnormal_ear_morphology | 0.63399126 |
| 106 | MP0004043_abnormal_pH_regulation | 0.62667409 |
| 107 | MP0005167_abnormal_blood-brain_barrier | 0.62371372 |
| 108 | MP0004130_abnormal_muscle_cell | 0.61593850 |
| 109 | MP0006072_abnormal_retinal_apoptosis | 0.61117576 |
| 110 | MP0001765_abnormal_ion_homeostasis | 0.60612547 |
| 111 | MP0005595_abnormal_vascular_smooth | 0.60390296 |
| 112 | MP0002972_abnormal_cardiac_muscle | 0.59019606 |
| 113 | MP0003861_abnormal_nervous_system | 0.57735719 |
| 114 | MP0005165_increased_susceptibility_to | 0.56698854 |
| 115 | MP0004142_abnormal_muscle_tone | 0.56043209 |
| 116 | MP0003183_abnormal_peptide_metabolism | 0.55754055 |
| 117 | MP0004036_abnormal_muscle_relaxation | 0.54684387 |
| 118 | MP0003690_abnormal_glial_cell | 0.52955292 |
| 119 | MP0000639_abnormal_adrenal_gland | 0.52560480 |
| 120 | MP0005623_abnormal_meninges_morphology | 0.51037821 |
| 121 | MP0005379_endocrine/exocrine_gland_phen | 0.50596015 |
| 122 | MP0000534_abnormal_ureter_morphology | 0.50440171 |
| 123 | MP0005620_abnormal_muscle_contractility | 0.50115079 |
| 124 | MP0005410_abnormal_fertilization | 0.50028982 |
| 125 | MP0003956_abnormal_body_size | 0.49858720 |
| 126 | MP0003121_genomic_imprinting | 0.49518659 |
| 127 | MP0010769_abnormal_survival | 0.45605612 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 6.89018416 |
| 2 | Visual hallucinations (HP:0002367) | 6.56898838 |
| 3 | Cerebral inclusion bodies (HP:0100314) | 5.95845170 |
| 4 | Myokymia (HP:0002411) | 5.56846509 |
| 5 | Hyperventilation (HP:0002883) | 5.11561913 |
| 6 | Focal seizures (HP:0007359) | 4.84632664 |
| 7 | Absence seizures (HP:0002121) | 4.09159905 |
| 8 | Atonic seizures (HP:0010819) | 4.07058792 |
| 9 | Neurofibrillary tangles (HP:0002185) | 4.04240712 |
| 10 | Epileptic encephalopathy (HP:0200134) | 4.03039371 |
| 11 | Delusions (HP:0000746) | 3.95796137 |
| 12 | Neuronal loss in central nervous system (HP:0002529) | 3.92226423 |
| 13 | Sensorimotor neuropathy (HP:0007141) | 3.88159566 |
| 14 | Dialeptic seizures (HP:0011146) | 3.80504229 |
| 15 | Ankle clonus (HP:0011448) | 3.79330075 |
| 16 | Slow saccadic eye movements (HP:0000514) | 3.76741939 |
| 17 | Impaired vibratory sensation (HP:0002495) | 3.67996775 |
| 18 | Amblyopia (HP:0000646) | 3.62112163 |
| 19 | Papilledema (HP:0001085) | 3.47647105 |
| 20 | Spastic gait (HP:0002064) | 3.35083211 |
| 21 | Generalized tonic-clonic seizures (HP:0002069) | 3.34180794 |
| 22 | Postural instability (HP:0002172) | 3.30002798 |
| 23 | Broad-based gait (HP:0002136) | 3.24674661 |
| 24 | Supranuclear gaze palsy (HP:0000605) | 3.23194833 |
| 25 | Mutism (HP:0002300) | 3.18262952 |
| 26 | Anxiety (HP:0000739) | 3.16857741 |
| 27 | Febrile seizures (HP:0002373) | 3.10902191 |
| 28 | Abnormality of saccadic eye movements (HP:0000570) | 3.05400004 |
| 29 | Drooling (HP:0002307) | 3.02322916 |
| 30 | Excessive salivation (HP:0003781) | 3.02322916 |
| 31 | Bundle branch block (HP:0011710) | 3.00993810 |
| 32 | Epileptiform EEG discharges (HP:0011182) | 2.99331407 |
| 33 | Abnormality of binocular vision (HP:0011514) | 2.93162557 |
| 34 | Diplopia (HP:0000651) | 2.93162557 |
| 35 | Dysautonomia (HP:0002459) | 2.89917927 |
| 36 | Megalencephaly (HP:0001355) | 2.86481408 |
| 37 | Abnormality of the corticospinal tract (HP:0002492) | 2.82625479 |
| 38 | Tetraplegia (HP:0002445) | 2.82493572 |
| 39 | Cerebral hypomyelination (HP:0006808) | 2.81306074 |
| 40 | Urinary urgency (HP:0000012) | 2.81217466 |
| 41 | Ventricular fibrillation (HP:0001663) | 2.79731506 |
| 42 | Oligodactyly (hands) (HP:0001180) | 2.76275606 |
| 43 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.75292082 |
| 44 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.75292082 |
| 45 | Annular pancreas (HP:0001734) | 2.73710743 |
| 46 | Acute necrotizing encephalopathy (HP:0006965) | 2.70894587 |
| 47 | EEG with generalized epileptiform discharges (HP:0011198) | 2.70718572 |
| 48 | Poor eye contact (HP:0000817) | 2.69295714 |
| 49 | Arterial tortuosity (HP:0005116) | 2.67219876 |
| 50 | Abnormality of the lower motor neuron (HP:0002366) | 2.65231762 |
| 51 | Limb dystonia (HP:0002451) | 2.63486965 |
| 52 | Truncal ataxia (HP:0002078) | 2.63294083 |
| 53 | Intention tremor (HP:0002080) | 2.63008062 |
| 54 | Sudden death (HP:0001699) | 2.58482875 |
| 55 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.57697482 |
| 56 | Hemiparesis (HP:0001269) | 2.56519734 |
| 57 | Syncope (HP:0001279) | 2.53819691 |
| 58 | Depression (HP:0000716) | 2.52214467 |
| 59 | Progressive macrocephaly (HP:0004481) | 2.48583023 |
| 60 | Lower limb muscle weakness (HP:0007340) | 2.47985340 |
| 61 | Hypsarrhythmia (HP:0002521) | 2.47915186 |
| 62 | Calcaneovalgus deformity (HP:0001848) | 2.44675538 |
| 63 | Global brain atrophy (HP:0002283) | 2.39255605 |
| 64 | Limb ataxia (HP:0002070) | 2.36786859 |
| 65 | Psychosis (HP:0000709) | 2.36471634 |
| 66 | Inability to walk (HP:0002540) | 2.33105818 |
| 67 | Polyphagia (HP:0002591) | 2.32712537 |
| 68 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.32138900 |
| 69 | Progressive cerebellar ataxia (HP:0002073) | 2.29763613 |
| 70 | Akinesia (HP:0002304) | 2.29622826 |
| 71 | Deformed tarsal bones (HP:0008119) | 2.29534574 |
| 72 | Abnormal social behavior (HP:0012433) | 2.28891170 |
| 73 | Impaired social interactions (HP:0000735) | 2.28891170 |
| 74 | Progressive inability to walk (HP:0002505) | 2.27886273 |
| 75 | Sleep apnea (HP:0010535) | 2.27832985 |
| 76 | Vascular tortuosity (HP:0004948) | 2.27720675 |
| 77 | Heart block (HP:0012722) | 2.27385001 |
| 78 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.27358695 |
| 79 | Obstructive sleep apnea (HP:0002870) | 2.26842452 |
| 80 | Acute encephalopathy (HP:0006846) | 2.25641701 |
| 81 | Absent speech (HP:0001344) | 2.25227895 |
| 82 | Action tremor (HP:0002345) | 2.24439831 |
| 83 | Hemiplegia (HP:0002301) | 2.20556554 |
| 84 | Dysmetria (HP:0001310) | 2.20291523 |
| 85 | Rapidly progressive (HP:0003678) | 2.18380543 |
| 86 | Gait ataxia (HP:0002066) | 2.16692401 |
| 87 | Mitochondrial inheritance (HP:0001427) | 2.16251072 |
| 88 | Rigidity (HP:0002063) | 2.12837123 |
| 89 | Dysdiadochokinesis (HP:0002075) | 2.12159626 |
| 90 | Brittle hair (HP:0002299) | 2.11892356 |
| 91 | Split foot (HP:0001839) | 2.10799011 |
| 92 | Abnormality of salivation (HP:0100755) | 2.09038044 |
| 93 | Clonus (HP:0002169) | 2.05260638 |
| 94 | Thickened helices (HP:0000391) | 2.02890181 |
| 95 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.01212397 |
| 96 | Incomplete penetrance (HP:0003829) | 2.01212244 |
| 97 | Abnormal atrioventricular conduction (HP:0005150) | 2.00048844 |
| 98 | Abnormal EKG (HP:0003115) | 1.99848451 |
| 99 | Choreoathetosis (HP:0001266) | 1.99821472 |
| 100 | Testicular atrophy (HP:0000029) | 1.99686306 |
| 101 | Double outlet right ventricle (HP:0001719) | 1.99320558 |
| 102 | Congenital malformation of the right heart (HP:0011723) | 1.99320558 |
| 103 | Hydroureter (HP:0000072) | 1.98642372 |
| 104 | Focal dystonia (HP:0004373) | 1.98477680 |
| 105 | Rhinitis (HP:0012384) | 1.97807343 |
| 106 | Stereotypic behavior (HP:0000733) | 1.97211083 |
| 107 | Torticollis (HP:0000473) | 1.96718708 |
| 108 | Absent/shortened dynein arms (HP:0200106) | 1.96082841 |
| 109 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.96082841 |
| 110 | Gait imbalance (HP:0002141) | 1.95214023 |
| 111 | Abnormal ciliary motility (HP:0012262) | 1.95184472 |
| 112 | Atrioventricular block (HP:0001678) | 1.95126511 |
| 113 | Primary atrial arrhythmia (HP:0001692) | 1.94661298 |
| 114 | Generalized myoclonic seizures (HP:0002123) | 1.94032833 |
| 115 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.93256538 |
| 116 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.93256538 |
| 117 | Mixed hearing impairment (HP:0000410) | 1.92904692 |
| 118 | Atrial fibrillation (HP:0005110) | 1.91264384 |
| 119 | Prolonged QT interval (HP:0001657) | 1.91068336 |
| 120 | Abnormality of the antihelix (HP:0009738) | 1.90182165 |
| 121 | Palpebral edema (HP:0100540) | 1.90166823 |
| 122 | Fair hair (HP:0002286) | 1.89876934 |
| 123 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.89862187 |
| 124 | Termporal pattern (HP:0011008) | 1.89587351 |
| 125 | Insidious onset (HP:0003587) | 1.89587351 |
| 126 | Athetosis (HP:0002305) | 1.88898824 |
| 127 | Gaze-evoked nystagmus (HP:0000640) | 1.88717853 |
| 128 | Bradykinesia (HP:0002067) | 1.88248510 |
| 129 | Supraventricular tachycardia (HP:0004755) | 1.87966956 |
| 130 | Humeroradial synostosis (HP:0003041) | 1.86052392 |
| 131 | Synostosis involving the elbow (HP:0003938) | 1.86052392 |
| 132 | Unsteady gait (HP:0002317) | 1.84745435 |
| 133 | Slow progression (HP:0003677) | 1.84268775 |
| 134 | Impaired smooth pursuit (HP:0007772) | 1.83997765 |
| 135 | Retinal dysplasia (HP:0007973) | 1.81468586 |
| 136 | Craniofacial dystonia (HP:0012179) | 1.81134440 |
| 137 | Heterochromia iridis (HP:0001100) | 1.80784270 |
| 138 | Apathy (HP:0000741) | 1.80434926 |
| 139 | Supraventricular arrhythmia (HP:0005115) | 1.79910281 |
| 140 | Status epilepticus (HP:0002133) | 1.78460885 |
| 141 | Medial flaring of the eyebrow (HP:0010747) | 1.76847680 |
| 142 | Abnormal autonomic nervous system physiology (HP:0012332) | 1.76533554 |
| 143 | Bronchomalacia (HP:0002780) | 1.75786432 |
| 144 | Oligodactyly (HP:0012165) | 1.75293419 |
| 145 | Abnormal gallbladder physiology (HP:0012438) | 1.75071382 |
| 146 | Cholecystitis (HP:0001082) | 1.75071382 |
| 147 | Protruding tongue (HP:0010808) | 1.74596226 |
| 148 | Anosmia (HP:0000458) | 1.73028746 |
| 149 | Amyotrophic lateral sclerosis (HP:0007354) | 1.71812151 |
| 150 | Deep palmar crease (HP:0006191) | 1.71782537 |
| 151 | Congenital primary aphakia (HP:0007707) | 1.71471619 |
| 152 | Increased CSF lactate (HP:0002490) | 1.71251769 |
| 153 | Orthostatic hypotension (HP:0001278) | 1.71137678 |
| 154 | Decreased circulating renin level (HP:0003351) | 1.70744059 |
| 155 | Abnormal eating behavior (HP:0100738) | 1.70434259 |
| 156 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.69594507 |
| 157 | Lower limb asymmetry (HP:0100559) | 1.69191355 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 6.19558065 |
| 2 | NTRK3 | 4.00686692 |
| 3 | RIPK4 | 3.87801680 |
| 4 | MAP3K12 | 3.02573987 |
| 5 | PLK2 | 2.93378633 |
| 6 | MAP3K9 | 2.78874065 |
| 7 | PTK2B | 2.78179498 |
| 8 | FGR | 2.69571559 |
| 9 | MINK1 | 2.68647758 |
| 10 | GRK6 | 2.43300012 |
| 11 | GRK5 | 2.36742873 |
| 12 | MAP3K4 | 2.25827963 |
| 13 | PNCK | 2.25143003 |
| 14 | NME1 | 2.03051434 |
| 15 | ARAF | 2.01631701 |
| 16 | MAP2K7 | 2.01480577 |
| 17 | BMPR2 | 2.01480506 |
| 18 | KSR2 | 1.89627925 |
| 19 | KSR1 | 1.80811629 |
| 20 | CASK | 1.77293157 |
| 21 | MAP3K13 | 1.73897493 |
| 22 | DAPK1 | 1.73047933 |
| 23 | MAP2K4 | 1.66551559 |
| 24 | DAPK2 | 1.57159048 |
| 25 | PRPF4B | 1.56626277 |
| 26 | PINK1 | 1.55286914 |
| 27 | LMTK2 | 1.46820079 |
| 28 | SIK2 | 1.45177568 |
| 29 | PRKD3 | 1.44190642 |
| 30 | CAMKK2 | 1.32254813 |
| 31 | CAMK2A | 1.30549572 |
| 32 | MARK1 | 1.30237818 |
| 33 | CDK5 | 1.27976823 |
| 34 | FES | 1.25964231 |
| 35 | PRKCG | 1.20998348 |
| 36 | NTRK2 | 1.19142462 |
| 37 | CAMK2B | 1.14631683 |
| 38 | DYRK1A | 1.12645232 |
| 39 | TESK1 | 1.10934188 |
| 40 | RAF1 | 1.10393458 |
| 41 | CDK19 | 1.00047137 |
| 42 | FER | 0.99694546 |
| 43 | DAPK3 | 0.95809126 |
| 44 | TNIK | 0.94934667 |
| 45 | NTRK1 | 0.92680818 |
| 46 | PRKCH | 0.90228623 |
| 47 | ALK | 0.88849551 |
| 48 | MAP3K2 | 0.86601115 |
| 49 | PAK6 | 0.84927088 |
| 50 | STK38 | 0.81415019 |
| 51 | MAPK12 | 0.79444956 |
| 52 | PDK3 | 0.79143089 |
| 53 | PDK4 | 0.79143089 |
| 54 | PKN1 | 0.77102470 |
| 55 | RIPK1 | 0.76016631 |
| 56 | CAMKK1 | 0.75089145 |
| 57 | DMPK | 0.74888116 |
| 58 | NEK6 | 0.72488216 |
| 59 | CAMK2D | 0.70047576 |
| 60 | MAPK13 | 0.69730302 |
| 61 | TAOK2 | 0.69528219 |
| 62 | CDK14 | 0.69012281 |
| 63 | BRSK1 | 0.68408792 |
| 64 | PHKG2 | 0.67689926 |
| 65 | PHKG1 | 0.67689926 |
| 66 | STK11 | 0.67518458 |
| 67 | OXSR1 | 0.66058228 |
| 68 | PLK3 | 0.65802520 |
| 69 | LIMK1 | 0.65180555 |
| 70 | BCR | 0.64348202 |
| 71 | CDK18 | 0.63523619 |
| 72 | SGK1 | 0.62809208 |
| 73 | MST4 | 0.61616824 |
| 74 | CDK15 | 0.58640352 |
| 75 | ROCK2 | 0.58250441 |
| 76 | SGK494 | 0.55198188 |
| 77 | SGK223 | 0.55198188 |
| 78 | MOS | 0.54188336 |
| 79 | PRKCE | 0.53493825 |
| 80 | BRAF | 0.53207770 |
| 81 | MARK2 | 0.51772242 |
| 82 | LATS2 | 0.50898517 |
| 83 | CAMK4 | 0.50871226 |
| 84 | CDK11A | 0.49228305 |
| 85 | SGK3 | 0.47811538 |
| 86 | PAK3 | 0.46775342 |
| 87 | PRKCZ | 0.46516949 |
| 88 | PRKD2 | 0.45813565 |
| 89 | MAP3K1 | 0.44982718 |
| 90 | MAP3K6 | 0.42221653 |
| 91 | RET | 0.42204529 |
| 92 | MAP2K1 | 0.40191222 |
| 93 | ADRBK1 | 0.39740828 |
| 94 | PDPK1 | 0.38987567 |
| 95 | CAMK2G | 0.38807242 |
| 96 | PRKG1 | 0.36917872 |
| 97 | PRKCQ | 0.36829469 |
| 98 | CSNK1G2 | 0.35648596 |
| 99 | TYRO3 | 0.35513093 |
| 100 | TRIM28 | 0.34635690 |
| 101 | ROCK1 | 0.34105585 |
| 102 | SIK3 | 0.33672762 |
| 103 | PDK2 | 0.33626505 |
| 104 | FYN | 0.33252450 |
| 105 | CAMK1 | 0.32806912 |
| 106 | PAK1 | 0.32723073 |
| 107 | SGK2 | 0.30879082 |
| 108 | MAP3K7 | 0.30287479 |
| 109 | PRKACA | 0.30059585 |
| 110 | UHMK1 | 0.29095430 |
| 111 | MYLK | 0.27922874 |
| 112 | MAPK10 | 0.27189991 |
| 113 | PRKCA | 0.26316994 |
| 114 | BMX | 0.26285990 |
| 115 | GRK7 | 0.26284640 |
| 116 | CCNB1 | 0.25398298 |
| 117 | PDK1 | 0.25323237 |
| 118 | CSNK1E | 0.25132100 |
| 119 | MAP3K11 | 0.24112718 |
| 120 | RPS6KA3 | 0.23561667 |
| 121 | IRAK2 | 0.23241372 |
| 122 | SYK | 0.23063088 |
| 123 | ABL2 | 0.21703609 |
| 124 | PRKCB | 0.20747754 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.29147918 |
| 2 | Long-term potentiation_Homo sapiens_hsa04720 | 3.46953450 |
| 3 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.97501371 |
| 4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.82386736 |
| 5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.71575274 |
| 6 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.66279808 |
| 7 | Olfactory transduction_Homo sapiens_hsa04740 | 2.63380398 |
| 8 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.53642148 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 2.41325775 |
| 10 | GABAergic synapse_Homo sapiens_hsa04727 | 2.34361270 |
| 11 | Salivary secretion_Homo sapiens_hsa04970 | 2.33520481 |
| 12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.26643681 |
| 13 | Renin secretion_Homo sapiens_hsa04924 | 2.26120413 |
| 14 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.22895832 |
| 15 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.04473422 |
| 16 | Alzheimers disease_Homo sapiens_hsa05010 | 1.97165435 |
| 17 | Taste transduction_Homo sapiens_hsa04742 | 1.96789142 |
| 18 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.92627010 |
| 19 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.89785644 |
| 20 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.88566881 |
| 21 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.88168378 |
| 22 | Long-term depression_Homo sapiens_hsa04730 | 1.74724839 |
| 23 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.74192138 |
| 24 | Phototransduction_Homo sapiens_hsa04744 | 1.70557884 |
| 25 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.67086447 |
| 26 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.60895264 |
| 27 | Parkinsons disease_Homo sapiens_hsa05012 | 1.53503692 |
| 28 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.51266365 |
| 29 | Insulin secretion_Homo sapiens_hsa04911 | 1.48130372 |
| 30 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.45924816 |
| 31 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.40118717 |
| 32 | Cocaine addiction_Homo sapiens_hsa05030 | 1.38985784 |
| 33 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.36927214 |
| 34 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.36925511 |
| 35 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.35316062 |
| 36 | Gap junction_Homo sapiens_hsa04540 | 1.33579943 |
| 37 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.29819446 |
| 38 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.28671297 |
| 39 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.26960027 |
| 40 | Melanogenesis_Homo sapiens_hsa04916 | 1.25944649 |
| 41 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.23481230 |
| 42 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.23473948 |
| 43 | Axon guidance_Homo sapiens_hsa04360 | 1.20831141 |
| 44 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.18405211 |
| 45 | Huntingtons disease_Homo sapiens_hsa05016 | 1.10526558 |
| 46 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.09620342 |
| 47 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.08516932 |
| 48 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.07680027 |
| 49 | Glioma_Homo sapiens_hsa05214 | 1.07338559 |
| 50 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.04865910 |
| 51 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.00103072 |
| 52 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.99843248 |
| 53 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.97778926 |
| 54 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.88691741 |
| 55 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.86300992 |
| 56 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.85486142 |
| 57 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.82339557 |
| 58 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.79215795 |
| 59 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.78438985 |
| 60 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.77647575 |
| 61 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.76243072 |
| 62 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.75341324 |
| 63 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.73882890 |
| 64 | Circadian rhythm_Homo sapiens_hsa04710 | 0.70326803 |
| 65 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.67673202 |
| 66 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.66671444 |
| 67 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.65995981 |
| 68 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.60868423 |
| 69 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.56645568 |
| 70 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.52494821 |
| 71 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.51705984 |
| 72 | Prion diseases_Homo sapiens_hsa05020 | 0.49131910 |
| 73 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.47475610 |
| 74 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.46707435 |
| 75 | Histidine metabolism_Homo sapiens_hsa00340 | 0.46621089 |
| 76 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.46290844 |
| 77 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.43960434 |
| 78 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.43590115 |
| 79 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.40491127 |
| 80 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.39752419 |
| 81 | Alcoholism_Homo sapiens_hsa05034 | 0.38825271 |
| 82 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.37618759 |
| 83 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.37010338 |
| 84 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.35116503 |
| 85 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.34749911 |
| 86 | Mineral absorption_Homo sapiens_hsa04978 | 0.33831544 |
| 87 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.32428103 |
| 88 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.32213893 |
| 89 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.31882384 |
| 90 | Bile secretion_Homo sapiens_hsa04976 | 0.31841308 |
| 91 | Tight junction_Homo sapiens_hsa04530 | 0.30881991 |
| 92 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.28668811 |
| 93 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.28300569 |
| 94 | Endocytosis_Homo sapiens_hsa04144 | 0.28230126 |
| 95 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.27780923 |
| 96 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.27543274 |
| 97 | Carbon metabolism_Homo sapiens_hsa01200 | 0.24468802 |
| 98 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.24218440 |
| 99 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.23942310 |
| 100 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.23445640 |
| 101 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.22292348 |
| 102 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.22112257 |
| 103 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.21699601 |
| 104 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.21296482 |
| 105 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.20673373 |
| 106 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.20572535 |
| 107 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.20067847 |
| 108 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.19696284 |
| 109 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.19650244 |
| 110 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.18842668 |
| 111 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.17890979 |
| 112 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.17707343 |
| 113 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.12555291 |
| 114 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.12495147 |
| 115 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.11722727 |
| 116 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.09809455 |
| 117 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.08579429 |
| 118 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.08318409 |
| 119 | Phagosome_Homo sapiens_hsa04145 | 0.08303209 |

